22 November 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC on ...
20 November 2023 - Foundation Medicine today announced that it has received approval from the US FDA for FoundationOne CDx ...
9 October 2023 - Foundation Medicine’s tissue based comprehensive genomic profiling test is now FDA approved to identify patients with ...
3 October 2023 - The US FDA has granted approval for EntroGen's CRCdx RAS Mutation Detection Kit as a companion diagnostic ...
14 August 2023 - Foundation Medicine’s tissue-based comprehensive genomic profiling test is now FDA approved to identify patients with metastatic castration-resistant ...
7 August 2023 - QIAGEN’s therascreen PDGFRA RGQ PCR kit approved in US to aid in identifying patients with unresectable or ...
21 July 2023 - Invivoscribe is excited to announce that the LeukoStrat CDx FLT3 mutation assay has been approved by ...
29 June 2023 - FDA issues simultaneous approval of Roctavian (valoctocogene roxaparvovec-rvox), BioMarin's gene therapy for severe haemophilia A. ...
20 June 2023 - Pilot geared toward sponsors of certain oncology drug products used with certainin vitro diagnostic tests ...
9 June 2023 - Foundation Medicine today announced that it has received approval from the US FDA for FoundationOne Liquid ...
13 December 2022 - therascreen KRAS RGQ PCR kit approved as a companion diagnostic to aid in identifying non-small-cell lung cancer ...
12 December 2022 - Agilent Technologies announced today that the US FDA has approved Agilent Resolution ctDx First as a ...
4 October 2022 - Approximately half of all patients with metastatic breast cancer express low levels of HER2. ...
27 July 2022 - 12 agenda items for consideration at the 24-25 November 2022 meeting. ...
7 July 2022 - The EMA) has finalised guidance on companion diagnostics, addressing procedural aspects to facilitate consultation between EMA ...